A novel radioguided surgery (RGS) technique for cerebral tumors using beta- radiation is being developed. Checking for a radiotracer that can deliver a beta- emitter to the tumor is a fundamental step in the deployment of such a technique. This paper reports a study of the uptake of 90Y- DOTATOC in meningiomas and high-grade gliomas (HGGs) and a feasibility study of the RGS technique in these types of tumor. Estimates were performed assuming the use of a beta probe under development with a sensitive area 2.55 mm in radius to detect 0.1-mL residuals. Methods: Uptake and background from healthy tissues were estimated on 68Ga-DOTATOC PET scans of 11 meningioma patients and 12 HGG patients. A dedicated statistical analysis of the DICOM images was developed and validated. The feasibility study was performed using full simulation of emission and detection of the radiation, accounting for the measured uptake and background rate. Results: All meningioma patients but one with an atypical extracranial tumor showed high uptake of DOTATOC. In terms of feasibility of the RGS technique, we estimated that by administering a 3 MBq/kg activity of radiotracer, the time needed to detect a 0.1-mL remnant with 5% false-negative and 1% false positive rates is less than 1 s. Actually, to achieve a detection time of 1 s the required activities to administer were as low as 0.2–0.5 MBq/kg in many patients. In HGGs, the uptake was lower than in meningiomas, but the tumor-to-nontumor ratio was higher than 4, which implies that the tracer can still be effective for RGS. It was estimated that by administering 3 mBq/kg of radiotracer, the time needed to detect a 0.1-mL remnant is less than 6 s, with the exception of the only oligodendroma in the sample. Conclusion: Uptake of 90Y-DOTATOC in meningiomas was high in all studied patients. Uptake in HGGs was significantly worse than in meningi omas but was still acceptable for RGS, particularly if further research and development are done to improve the performance of the beta probe.

Toward Radioguided Surgery with beta(-) Decays: Uptake of a Somatostatin Analogue, DOTATOC, in Meningioma and High-Grade Glioma / Collamati, Francesco; Pepe, Alessandra; Bellini, Fabio; Bocci, Valerio; Chiodi, Giacomo; Cremonesi, Marta; DE LUCIA, Erika; Ferrari, Mahila E.; Frallicciardi, Paola M.; Grana, Chiara M.; Marafini, Michela; Mattei, Ilaria; Morganti, Silvio; Patera, Vincenzo; Piersanti, Luca; Recchia, Luigi; Russomando, Andrea; Sarti, Alessio; Sciubba, Adalberto; Senzacqua, Martina; SOLFAROLI CAMILLOCCI, Elena; Voena, Cecilia; Pinci, Davide; Faccini, Riccardo. - In: THE JOURNAL OF NUCLEAR MEDICINE. - ISSN 0161-5505. - 56:1(2015), pp. 3-8. [10.2967/jnumed.114.145995]

Toward Radioguided Surgery with beta(-) Decays: Uptake of a Somatostatin Analogue, DOTATOC, in Meningioma and High-Grade Glioma

BELLINI, Fabio;PATERA, Vincenzo;SARTI, ALESSIO;SCIUBBA, Adalberto;SOLFAROLI CAMILLOCCI, ELENA;VOENA, Cecilia;FACCINI, Riccardo
2015

Abstract

A novel radioguided surgery (RGS) technique for cerebral tumors using beta- radiation is being developed. Checking for a radiotracer that can deliver a beta- emitter to the tumor is a fundamental step in the deployment of such a technique. This paper reports a study of the uptake of 90Y- DOTATOC in meningiomas and high-grade gliomas (HGGs) and a feasibility study of the RGS technique in these types of tumor. Estimates were performed assuming the use of a beta probe under development with a sensitive area 2.55 mm in radius to detect 0.1-mL residuals. Methods: Uptake and background from healthy tissues were estimated on 68Ga-DOTATOC PET scans of 11 meningioma patients and 12 HGG patients. A dedicated statistical analysis of the DICOM images was developed and validated. The feasibility study was performed using full simulation of emission and detection of the radiation, accounting for the measured uptake and background rate. Results: All meningioma patients but one with an atypical extracranial tumor showed high uptake of DOTATOC. In terms of feasibility of the RGS technique, we estimated that by administering a 3 MBq/kg activity of radiotracer, the time needed to detect a 0.1-mL remnant with 5% false-negative and 1% false positive rates is less than 1 s. Actually, to achieve a detection time of 1 s the required activities to administer were as low as 0.2–0.5 MBq/kg in many patients. In HGGs, the uptake was lower than in meningiomas, but the tumor-to-nontumor ratio was higher than 4, which implies that the tracer can still be effective for RGS. It was estimated that by administering 3 mBq/kg of radiotracer, the time needed to detect a 0.1-mL remnant is less than 6 s, with the exception of the only oligodendroma in the sample. Conclusion: Uptake of 90Y-DOTATOC in meningiomas was high in all studied patients. Uptake in HGGs was significantly worse than in meningi omas but was still acceptable for RGS, particularly if further research and development are done to improve the performance of the beta probe.
2015
radioguided surgery; somatostatin analogue; meningioma; high-grade glioma
01 Pubblicazione su rivista::01a Articolo in rivista
Toward Radioguided Surgery with beta(-) Decays: Uptake of a Somatostatin Analogue, DOTATOC, in Meningioma and High-Grade Glioma / Collamati, Francesco; Pepe, Alessandra; Bellini, Fabio; Bocci, Valerio; Chiodi, Giacomo; Cremonesi, Marta; DE LUCIA, Erika; Ferrari, Mahila E.; Frallicciardi, Paola M.; Grana, Chiara M.; Marafini, Michela; Mattei, Ilaria; Morganti, Silvio; Patera, Vincenzo; Piersanti, Luca; Recchia, Luigi; Russomando, Andrea; Sarti, Alessio; Sciubba, Adalberto; Senzacqua, Martina; SOLFAROLI CAMILLOCCI, Elena; Voena, Cecilia; Pinci, Davide; Faccini, Riccardo. - In: THE JOURNAL OF NUCLEAR MEDICINE. - ISSN 0161-5505. - 56:1(2015), pp. 3-8. [10.2967/jnumed.114.145995]
File allegati a questo prodotto
File Dimensione Formato  
Collamati_Toward_2015.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 757.34 kB
Formato Adobe PDF
757.34 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/954516
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 54
  • ???jsp.display-item.citation.isi??? 51
social impact